These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 16607096)

  • 1. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.
    MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW
    Menopause; 2006; 13(1):28-36. PubMed ID: 16607096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone therapy and cognition: effects of timing and treatment type.
    Khoo SK; O'Neill S; Byrne G; King R; Travers C; Tripcony L
    Climacteric; 2010 Jun; 13(3):259-64. PubMed ID: 19886816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No differences in performance on test of working memory and executive functioning between healthy elderly postmenopausal women using or not using hormone therapy.
    Grigorova M; Sherwin BB
    Climacteric; 2006 Jun; 9(3):181-94. PubMed ID: 16766432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.
    Komulainen P; Pedersen M; Hänninen T; Bruunsgaard H; Lakka TA; Kivipelto M; Hassinen M; Rauramaa TH; Pedersen BK; Rauramaa R
    Neurobiol Learn Mem; 2008 Nov; 90(4):596-603. PubMed ID: 18707012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.
    Kanaya AM; Barrett-Connor E; Gildengorin G; Yaffe K
    Arch Intern Med; 2004 Jun; 164(12):1327-33. PubMed ID: 15226167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years.
    Low LF; Anstey KJ; Jorm AF; Christensen H; Rodgers B
    Maturitas; 2006 Apr; 54(1):86-94. PubMed ID: 16226000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone therapy and its association with cognitive impairment.
    Mitchell JL; Cruickshanks KJ; Klein BE; Palta M; Nondahl DM
    Arch Intern Med; 2003 Nov; 163(20):2485-90. PubMed ID: 14609785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
    Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
    Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: the Guangzhou Biobank Cohort Study.
    Heys M; Jiang C; Cheng KK; Zhang W; Au Yeung SL; Lam TH; Leung GM; Schooling CM
    Psychoneuroendocrinology; 2011 Jul; 36(6):864-73. PubMed ID: 21185655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oophorectomy status and bone density in older, hysterectomized women.
    Kritz-Silverstein D; Barrett-Connor E
    Am J Prev Med; 1996; 12(5):424-9. PubMed ID: 8909657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical versus natural menopause: cognitive issues.
    Henderson VW; Sherwin BB
    Menopause; 2007; 14(3 Pt 2):572-9. PubMed ID: 17476147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of cognition change during early menopausal transition in a rural community.
    Fuh JL; Wang SJ; Lee SJ; Lu SR; Juang KD
    Maturitas; 2006 Mar; 53(4):447-53. PubMed ID: 16198073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function in late versus early postmenopausal stage.
    Elsabagh S; Hartley DE; File SE
    Maturitas; 2007 Jan; 56(1):84-93. PubMed ID: 16857328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.
    Pefanco MA; Kenny AM; Kaplan RF; Kuchel G; Walsh S; Kleppinger A; Prestwood K
    J Am Geriatr Soc; 2007 Mar; 55(3):426-31. PubMed ID: 17341247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.